Podiatrist, Primary Podiatric Medicine · Brooklyn, NY
NPI
1740226448
Since 2006
Specialty
Podiatrist, Primary Podiatric Medicine
Code 213EP1101X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
420 Fulton St, 6th Floor
Brooklyn, NY, 11201
Phone (718) 797-3668
Groups this clinician bills Medicare through
Medicare paid, 2024
$144K
2,403 services
Medicare patients, 2024
328
Average age 76
Drug cost, 2024
$1.9M
3,141 prescriptions
Company payments, 2025
$17.71
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Dawn A Yamashita was code 99213 (office e&m - established), 958 times for 292 patients. In total Dawn A Yamashita billed 2,403 services in 18 codes, and Medicare paid $144K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2008-04-10.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 958 | 292 | $72.98 | $70K |
| 11721 Nail Procedure | Office | 567 | 236 | $36.53 | $21K |
| 11056 Removal or Shaving of Skin Growth | Office | 388 | 158 | $68.27 | $26K |
| 99212 Office E&M - Established | Office | 277 | 178 | $46.44 | $13K |
| 11057 Removal or Shaving of Skin Growth | Office | 83 | 44 | $74.76 | $6,205 |
| 11720 Nail Procedure | Office | 51 | 38 | $27.24 | $1,389 |
| 99203 Office E&M - New | Office | 29 | 29 | $91.51 | $2,654 |
By year: 2022 $121K for 1,751 services; 2023 $115K for 1,578 services; 2024 $144K for 2,403 services.
Medicare prescription drug claims, 2024
In 2024, the drug Dawn A Yamashita prescribed most often to Medicare patients was Jublia (Efinaconazole), with 993 prescriptions and refills. In total Dawn A Yamashita wrote 3,141 Medicare prescriptions that cost $1.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Jublia Efinaconazole | 993 | 997 | 135 | $1.4M |
| Ammonium Lactate Generic | 954 | 990 | 173 | $16K |
| Eucrisa Crisaborole | 309 | 323 | 46 | $281K |
| Ciclopirox Ciclopirox Olamine | 289 | 365 | 63 | $6,186 |
| Diclofenac Sodium Generic | 120 | 127 | 33 | $58K |
| Naftifine Hcl Generic | 100 | 101 | 11 | $29K |
| Mupirocin Generic | 71 | 72 | 18 | $341 |
| Tavaborole Generic | 57 | 115 | 25 | $66K |
| Naftin Naftifine Hcl | 54 | 58 | Under 11 | $29K |
| Ketoconazole Generic | 36 | 41 | Under 11 | $3,861 |
| Clotrimazole Generic | 26 | 26 | Under 11 | $258 |
| Fluticasone Propionate Generic | 24 | 24 | 14 | $1,781 |
| Ciclopirox Generic | 23 | 26 | Under 11 | $1,529 |
| Lidocaine Hcl Viscous Lidocaine Hcl | 16 | 16 | Under 11 | $945 |
| Nystatin Generic | 13 | 13 | Under 11 | $233 |
Brand drugs: - claims; generic drugs: 1,757 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Dawn A Yamashita $17.71 ($17.71 in general payments such as food, travel and fees) from 1 company. The largest payer was Heartflow, Inc. with $17.71.
| Company | Payments | Amount |
|---|---|---|
| Heartflow, Inc. HTFL | 1 | $17.71 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.